SCHEMBL5317567

SCHEMBL5317567

COC(=O)c1cc(N)ccc1OC(C)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.56
CFD P00746 2/20 0.47
KDM4E B2RXH2 6/20 0.47
NR3C1 P04150 1/20 0.45
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 5/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 2/20 0.44
GLA P06280 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
ATM Q13315 1/20 0.44
CFTR P13569 1/20 0.43
CYP19A1 P11511 1/20 0.43
NPC1 O15118 1/20 0.43
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ABL1 P00519 1/20 0.42
TSHR P16473 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9318003 0.87 CFD (0.47) GAACFDKDM4ENR3C1ALDH1A1
SCHEMBL15055753 0.87 GAA (0.60) GAAKDM4EALDH1A1HSD17B10HPGD
SCHEMBL570110 0.84 GAA (0.61) GAAKDM4EALDH1A1HSD17B10HPGD
Methoxymethane SCHEMBL5317565 0.83 CFD (0.65) GAACFDKDM4ENR3C1ALDH1A1
Hydrochloric Acid SCHEMBL15488205 0.83 GAA (0.59) GAAKDM4EALDH1A1HSD17B10HPGD
SCHEMBL138320 0.83 CFD (0.69) GAACFDKDM4ENR3C1ALDH1A1
Hydrochloric Acid SCHEMBL7564049 0.83 GAA (0.59) GAAKDM4EALDH1A1HSD17B10HPGD
SCHEMBL31618292 0.83 CFD (0.69) GAACFDKDM4ENR3C1ALDH1A1
SCHEMBL10334181 0.83 LMNA (0.50) GAACFDKDM4EALDH1A1HSD17B10
SCHEMBL11866557 0.81 GAA (0.50) GAAKDM4EALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 WO disclosed
WO-2007119984-A1 SALICYLIC ACID DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THEM NEUROTECH CO., LTD. (KR) 2007-10-25 WO disclosed
WO-2007119984-A1 SALICYLIC ACID DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THEM NEUROTECH CO., LTD. (KR) 2007-10-25 WO disclosed
US-4933330-A PSORIASIS DAK-LABORATORIET (DK) 1990-06-12 US disclosed
EP-0291159-A2 Aminosalicylic-acid derivatives for the treatment of psoriasis DAK-LABORATORIET A/S (DK) 1988-11-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 GAA 2196/4885CFD 3953/4885KDM4E 786/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 GAA 2196/4885CFD 3953/4885KDM4E 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.